Trials / Conditions / Neurofibromatosis 1 (NF1)
Neurofibromatosis 1 (NF1)
5 registered clinical trials studyying Neurofibromatosis 1 (NF1) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofi NCT06934928 | Massachusetts General Hospital | N/A |
| Not Yet Recruiting | Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Gra NCT07521657 | University of Alabama at Birmingham | Phase 2 |
| Not Yet Recruiting | Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST NCT06735820 | AeRang Kim | Phase 1 / Phase 2 |
| Active Not Recruiting | MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Ino NCT02407405 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Reliability of Functional Outcome Measures in Neurofibromatosis 1 NCT02479360 | Guy's and St Thomas' NHS Foundation Trust | — |